These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 2838745)

  • 1. Issues concerning the use of intravenous immunoglobulins for the immunoprophylaxis of cytomegalovirus infections in allogeneic bone marrow transplant recipients.
    Emanuel D
    Monogr Allergy; 1988; 23():216-24. PubMed ID: 2838745
    [No Abstract]   [Full Text] [Related]  

  • 2. Neutralizing antibody response against human cytomegalovirus in allogeneic bone marrow-transplant recipients.
    Volpi A; Pica F; Gentile G; Capobianchi A; Fraschetti M; Martino P
    J Infect Dis; 1999 Nov; 180(5):1747-8. PubMed ID: 10515847
    [No Abstract]   [Full Text] [Related]  

  • 3. Prevention of cytomegalovirus infection in bone marrow transplant recipients by prophylaxis with an intravenous, hyperimmune cytomegalovirus globulin.
    Condie RM; O'Reilly RJ
    Birth Defects Orig Artic Ser; 1984; 20(1):327-44. PubMed ID: 6329370
    [No Abstract]   [Full Text] [Related]  

  • 4. Cytomegalovirus infection in bone marrow transplant recipients: use of intravenous gamma globulin as a prophylactic and therapeutic agent.
    Kapoor N; Copelan EA; Tutschka PJ
    Transplant Proc; 1989 Feb; 21(1 Pt 3):3095-6. PubMed ID: 2539686
    [No Abstract]   [Full Text] [Related]  

  • 5. [Specific anti-cytomegalovirus immunoglobulins in the prevention of cytomegalovirus infections in bone marrow allografts].
    Huart JJ; Baume D; Jouet JP
    Ann Med Interne (Paris); 1987; 138(5):372-4. PubMed ID: 2823667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoprophylaxis of infections with human cytomegalovirus in BMT patients.
    Mach M; Landini MP
    Bone Marrow Transplant; 1993; 11 Suppl 1():95-6. PubMed ID: 8383558
    [No Abstract]   [Full Text] [Related]  

  • 7. Selection of an intravenous immune globulin for the immunoprophylaxis of cytomegalovirus infections: an in vitro comparison of currently available and previously effective immune globulins.
    Chehimi J; Peppard J; Emanuel D
    Bone Marrow Transplant; 1987 Dec; 2(4):395-402. PubMed ID: 2844341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune globulin (GAMMAGARD) prophylaxis of CMV infections in patients undergoing organ transplantation and allogeneic bone marrow transplantation.
    Fehir KM; Decker WA; Samo T; Young JB; Lederer E; Lawrence EC
    Transplant Proc; 1989 Feb; 21(1 Pt 3):3107-9. PubMed ID: 2539691
    [No Abstract]   [Full Text] [Related]  

  • 9. Efficacy of hyperimmune anti-cytomegalovirus immunoglobulins for the prevention of cytomegalovirus infection in recipients of allogeneic bone marrow transplantation: a meta-analysis.
    Messori A; Rampazzo R; Scroccaro G; Martini N
    Bone Marrow Transplant; 1994 Feb; 13(2):163-7. PubMed ID: 8205085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perspectives for the control of cytomegalovirus infections in bone marrow transplant recipients.
    Pollard RB; Merigan TC
    Transplant Proc; 1978 Mar; 10(1):241-5. PubMed ID: 205021
    [No Abstract]   [Full Text] [Related]  

  • 11. Prevention of cytomegalovirus disease in transplant recipients.
    Pidgeon GB; Bailey RR
    N Z Med J; 1993 Nov; 106(967):468-9. PubMed ID: 8233192
    [No Abstract]   [Full Text] [Related]  

  • 12. Cytomegalovirus infection in transplant patients.
    Betts RF
    Prog Med Virol; 1982; 28():44-64. PubMed ID: 6283602
    [No Abstract]   [Full Text] [Related]  

  • 13. Preliminary results of a multicenter trial to prevent death from cytomegalovirus pneumonia with intravenous immunoglobulin after allogeneic bone marrow transplantation.
    Elfenbein G; Krischer J; Rand K; Graham-Pole J; Jansen J; Winton E; Hong R; Lazarus H; Babington R
    Transplant Proc; 1987 Dec; 19(6 Suppl 7):138-43. PubMed ID: 2827359
    [No Abstract]   [Full Text] [Related]  

  • 14. Randomized double-blinded comparison of three intravenous immunoglobulin products in bone marrow transplantation.
    Peltier MK; Filipovich AH; Bechtel M; Dirksen CL; Englund JA
    Semin Hematol; 1992 Jul; 29(3 Suppl 2):112-5. PubMed ID: 1324529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytomegalovirus infections in the immunocompromised transplant patient. Prevention of cytomegalovirus disease with intravenous immune globulin.
    Snydman DR
    Transplant Proc; 1991 Apr; 23(2 Suppl 1):20-5. PubMed ID: 1647560
    [No Abstract]   [Full Text] [Related]  

  • 16. Interim results of a multicenter trial to prevent cytomegalovirus pneumonia after allogeneic bone marrow transplantation.
    Elfenbein G; Krischer J; Babington R; Hong R; Jansen J; Lazarus H; Winton E; Rand K
    Transplant Proc; 1989 Feb; 21(1 Pt 3):3099-100. PubMed ID: 2539688
    [No Abstract]   [Full Text] [Related]  

  • 17. Immune globulin therapy in allogeneic bone marrow transplant: a critical review.
    Guglielmo BJ; Wong-Beringer A; Linker CA
    Bone Marrow Transplant; 1994 May; 13(5):499-510. PubMed ID: 8054903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of human cytomegalovirus infection and disease after allogeneic bone marrow transplantation.
    Stocchi R; Ward KN; Fanin R; Baccarani M; Apperley JF
    Haematologica; 1999 Jan; 84(1):71-9. PubMed ID: 10091394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of association between the kinetics of human cytomegalovirus (HCMV) glycoprotein B (gB)-specific and neutralizing serum antibodies and development or recovery from HCMV active infection in patients undergoing allogeneic stem cell transplant.
    Muñoz I; Gutiérrez A; Gimeno C; Farga A; Alberola J; Solano C; Prósper F; García-Conde J; Navarro D
    J Med Virol; 2001 Sep; 65(1):77-84. PubMed ID: 11505447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytomegalovirus infection following marrow transplantation: risk, treatment, and prevention.
    Meyers JD
    Birth Defects Orig Artic Ser; 1984; 20(1):101-17. PubMed ID: 6329356
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.